Naproxen Flamingo Pharma Uk

Naproxen, the active ingredient in Naproxen Flamingo Pharma Uk, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve mild to moderate pain, inflammation and fever in adults. GNH USA supplies Naproxen Flamingo Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain in several musculoskeletal and gynecological conditions. - Mild to moderate pain: Provides analgesic relief for everyday aches and injuries. - Osteoarthritis: Decreases joint inflammation and improves mobility. - Rheumatoid arthritis: Helps control chronic joint inflammation and pain. - Dysmenorrhea: Relieves menstrual cramps and associated discomfort. - Musculoskeletal pain: Alleviates strain, sprain and back‑pain symptoms.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation. - Elevated blood pressure in some patients.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic enzyme elevation or liver injury. - Renal impairment or acute kidney injury. - Anaphylaxis or severe hypersensitivity reactions.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Assess gastrointestinal risk: use gastro‑protective agents if history of ulcer disease. - Evaluate cardiovascular history: avoid in patients with recent thrombotic events. - Monitor renal function: adjust or discontinue if renal insufficiency develops. - Use the lowest effective dose for the shortest duration needed. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Naproxen can alter the pharmacodynamics or pharmacokinetics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective COX‑2 inhibitors (e.g., celecoxib): additive renal and cardiovascular toxicity. - SSRIs or SNRIs: heightened risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Diuretics: may impair renal function when combined. - Methotrexate: naproxen can raise methotrexate plasma levels. - Lithium: risk of lithium toxicity may increase. - Corticosteroids: enhanced gastrointestinal ulcer risk.